Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis

Gut

Volumn 40, Issue 6, 1997, Pages 726-730

  Miyaji, H ^a   Ito, S ^a   Azuma, T ^a   Ito, Y ^a   Yamazaki, Y ^a   Ohtaki, Y ^a   Sato, F ^a   Hirai, M ^a   Kuriyama, M ^a   Kohli, Y ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b Aiseikai Yamashina Hospital   (Japan)

Author keywords

Helicobacter pylon; Hyperammonaemia; Liver cirrhosis; Urease

Indexed keywords

AMINOLEBAN; AMMONIA; AMOXICILLIN; BRANCHED CHAIN AMINO ACID; CLARITHROMYCIN; KANAMYCIN; LACTULOSE; LANSOPRAZOLE; METRONIDAZOLE; UNCLASSIFIED DRUG; UREASE;

ADULT; AMMONIA BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; COLONY FORMING UNIT; FEMALE; HELICOBACTER PYLORI; HUMAN; HYPERAMMONEMIA; INTESTINE FLORA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; PROTEIN RESTRICTION;

EID: 8544249125     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.6.726     Document Type: Article

References (37)

1. Felipo V, Minana MD, Grisolla S. Paradoxical protection of both protein-free and high protein diets against acute ammonium intoxication. Biochem Biophys Res Commun 1988; 156: 506-10.
2. Bircher J, Muller J, Guggenheim P, Haemmerli UP. Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet 1966; i: 890-2.
3. Elkington SG, Floch MH, Conn HO. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial. N Engl J Med 1969; 281: 408-12.
4. Mortensen PB. The effect of oral-administered lactulose on colonie nitrogen metabolism and excretion. Hepatology 1992; 16: 1350-6.
5. Van Thiel DH, Fagiuoli S, Wright HI, Chien MC, Gavaler JS. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment. Hepatology 1994; 19: 67-71.
6. Pirotte J, Guffens JM, Devos J. Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose and an association of neomycin and lactulose. Digestion 1974; 10: 435-44.
7. Wapnick S, Guinto R, Reizis I, LeVeen HH. Reduction of postoperative infection in elective colon surgery with preoperative administration of kanamycin and erythromycin. Surgery 1979; 85: 317-21.
8. Scevola D, Zambelli A, Concia E, Perversi L, Candiani C. Non-absorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other? Hepatology 1990; 12: 368-70.
9. Alexander T, Thomas K, Cherian AM, Kanakasabapathy. Effect of three antibacterial drugs in lowering blood and stool ammonia production in hepatic encephalopathy. Indian J Med Res 1992; 96: 292-6.
10. Voorhies TM, Ehrlich ME, Duffy TE, Petito CK, Plum F. Acute hyperammonemia in the young primate: physiologic and neuropathologic correlates. Pediatr Res 1983; 17: 970-5.
11. Blei AT, Olafsson S, Therrien G, Butterworth RF. Ammonia-induced brain edema and intracranial hypertention in rats after portacaval anastomosis. Hepatology 1944; 19: 1437-44.
12. Warren JR, Marshall BJ. Undentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; i: 1273-5.
13. Marshall BJ, Warren JR. Undentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-5.
14. Johnston BJ, Reed PI, Ali MH. Campylobacter like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation. Gut 1986; 27: 1132-7.
15. Blaser MJ. Helicobacter pylori and pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626-33.
16. Miyaji H, Kohli Y, Azuma T, Ito S, Hirai M, Ito Y, et al. Endoscopic cross-infection with Helicobacter pylori. Lancet 1995; 345: 464.
17. Talley NJ, Zinsmeister AR, Weaver A, DiMagno EP, Carpenter HA, Perez Perez GI, Blaser MJ. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991; 83: 1734-9.
18. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31.
19. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 83: 1132-6.
20. Blaser MJ, Kobayashi K, Cover TL, Cao P, Feurer ID, Perez-Perez GI. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach, Int J Cancer 1993; 55: 799-802.
21. Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-71.
22. Dunn BE, Campbell GP, Perez Perez GI, Blaser MJ. Purification and characterization of urease from Helicobacter pylori. J Biol Chem 1990; 265: 9464-9.
23. Perez Perez GI, Gower CB, Blaser MJ. Effect of cations on Helicobacter pylori urease activity, release, and stability. Infect Immun 1994; 62: 299-302.
24. Ito S, Kohli Y, Kato T, Murakita H, Ohtaki Y, Hirai M, et al. Differences in urease activity in live Helicobacter pylori cultured from patients with gastroduodenal diseases. Eur J Gastroenterol Hepatol 1995; 7 (suppl 1): S83-8.
25. Ito S, Kohli Y, Kato T, Abe M, Ueda T. Significance of ammonia produced by Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 167-74.
26. Ito S, Miyaji H, Azuma T, IJ Y, Ito Y, Kato T, et al. Hyperammonaemia and Helicobacter pylori. Lancet 1995; 346: 124-5.
27. Quero JC, Hartmann IJ, de Rooij F, Wilson JH, Schalm SW. Hyperammonaemia and Helicobacter pylori. Lancet 1995; 346: 713-4.
28. Plevris JN, Morgenstern R, Haves PC, Bouchier IA. Hyperammonaemia in cirrhosis and Helicobacter pylori infection. Lancet 1995; 346: 11104.
29. Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RI, et al. The role of plasma amino acids in hepatic encephalopaty. Surgery 1975; 78: 276-90.
30. Weber FL Jr, Bagby BS, Licate L, Kelsen SG. Effects of branched-chain amino acids on nitrogen metabolism in patients with cirrhosis. Hepatology 1990; 11: 942-50.
31. Higuchi K, Shimizu Y, Nambu S, Miyabayashi C, Takahara T, Saito S, et al. Effects of an infusion of branched-chain amino acids on neurophysiological and psychometric testings in cirrhotic patients with mild hepatic encephalopathy. J Gastroenterol Hepatol 1994; 9: 366-72.
32. Kohli Y, Kato T, Iwaki M, Yamazaki Y, Hata M, Suzuki K, Ito S. The distribution of Helicobacter pylori in human gastric mucosa in vivo. Dig Endosc 1991; 3: 457-60.
33. Kohli Y, Kato T, Iwaki M, Ito S, Suzuki K. Endoscopic diagnosis of Helicobacter pylori distribution in gastric mucosa of patients with chronic gastritis. Eur J Gastroenterol Hepatol 1993; 5 (suppl 1): S127-31.
34. Hosking SW, Ling TK, Chung SC, Yung MY, Cheng AF, Sung JJ, Li AK. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
35. Sung JJ, Chung SC, Ling TK, Yung MY, Leung VK, Ng EK, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.
36. Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
37. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, Collins BJ. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow up. Lancet 1994; 343: 258-60.